AbCellera Biologics (ABCL) Earnings Date, Estimates & Call Transcripts $2.65 -0.11 (-3.99%) (As of 11/15/2024 ET) Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends AbCellera Biologics Latest Earnings SummaryUpcoming Q4 Earnings DateFeb. 18EstimatedActual EPS (Nov. 4) -$0.17 Missed By -$0.03 Consensus EPS (Nov. 4) -$0.14 AbCellera Biologics released Q3 2024 earnings on November 4, 2024, reporting an EPS of -$0.17, which missed analysts' consensus estimates of -$0.14 by $0.03. Quarterly revenue was reported to be $6.51 million, below analysts' expectations of $8.95 million. With a trailing EPS of -$0.61, AbCellera Biologics' earnings are expected to decrease next year, from ($0.59) to ($0.71) per share. Conference Call TranscriptConference Call AudioEarnings Press ReleaseEarnings Slide DeckABCL Upcoming EarningsAbCellera Biologics' next earnings date is estimated for Tuesday, February 18, 2025, based off prior year's reporting schedules. Get AbCellera Biologics Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on AbCellera Biologics and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataABCL Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.ABCL Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Genesis Gold GroupTrump’s Back, but DC’s Coming for Your Money!Trump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy with a heavy hand—building up infrastructure, slapping tariffs on imports, and going all-in on U.S. jobs. But here's the kicker: while Trump's focused on making America stronger, the Washington elite is ready to fight back…Get ahead of the game with 3 proven strategies to protect your retirement from Washington's next mov AbCellera Biologics Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20243-$0.14-$0.08-$0.11Q2 20243-$0.15-$0.09-$0.13Q3 20243-$0.14-$0.05-$0.09Q4 20243-$0.15-$0.09-$0.11FY 202412-$0.58-$0.31-$0.45Q1 20251-$0.15-$0.15-$0.15Q2 20251-$0.15-$0.15-$0.15Q3 20251-$0.16-$0.16-$0.16Q4 20251-$0.17-$0.17-$0.17FY 20254($0.63)($0.63)($0.63) AbCellera Biologics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueLinks 2/18/2025(Estimated)------- 11/4/2024Q3 2024-$0.14-$0.17 -$0.03-$0.17$8.95M$6.51M 8/6/2024Q2 2024-$0.15-$0.13+$0.02-$0.13$10.12M$7.30M 5/7/2024Q1 2024-$0.16-$0.14+$0.02-$0.14$10.73M$9.95M 2/20/2024Q4 2023-$0.14-$0.17 -$0.03-$0.17$9.58M$9.18M 11/2/2023Q3 2023-$0.14-$0.10+$0.04-$0.10$11.92M$6.60M 8/3/2023Q2 2023-$0.13-$0.11+$0.02-$0.11$12.38M$10.10M Get the Latest News and Ratings for ABCL and Related StocksEnter your email address below to receive the latest news and analysts' ratings for AbCellera Biologics and its competitors with MarketBeat's FREE daily newsletter. 5/4/2023Q1 2023-$0.12-$0.14 -$0.02-$0.14$12.11M$12.20M 2/21/2023Q4 2022$0.01-$0.10 -$0.11-$0.10$50.80M$21.50M AbCellera Biologics Earnings - Frequently Asked Questions When is AbCellera Biologics's earnings date? AbCellera Biologics has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, February 18th, 2025 based off last year's report dates. Learn more on ABCL's earnings history. Did AbCellera Biologics beat their earnings estimates last quarter? In the previous quarter, AbCellera Biologics (NASDAQ:ABCL) missed the analysts' consensus estimate of ($0.14) by $0.03 with a reported earnings per share (EPS) of ($0.17). Learn more on analysts' earnings estimate vs. ABCL's actual earnings. How can I listen to AbCellera Biologics's earnings conference call? The conference call for AbCellera Biologics's latest earnings report can be listened to online. Listen to Conference Call How can I read AbCellera Biologics's conference call transcript? The conference call transcript for AbCellera Biologics's latest earnings report can be read online. Read Transcript How much revenue does AbCellera Biologics generate each year? AbCellera Biologics (NASDAQ:ABCL) has a recorded annual revenue of $38.03 million. How much profit does AbCellera Biologics generate each year? AbCellera Biologics (NASDAQ:ABCL) has a recorded net income of -$146.40 million. ABCL has generated -$0.61 earnings per share over the last four quarters. What is AbCellera Biologics's EPS forecast for next year? AbCellera Biologics's earnings are expected to decrease from ($0.59) per share to ($0.72) per share in the next year. ` More Earnings Resources from MarketBeat Related Companies Bausch Health Companies Earnings Results MoonLake Immunotherapeutics Earnings Results Agios Pharmaceuticals Earnings Results Xenon Pharmaceuticals Earnings Results PTC Therapeutics Earnings Results Edgewise Therapeutics Earnings Results Amicus Therapeutics Earnings Results Dyne Therapeutics Earnings Results MorphoSys Earnings Results Verona Pharma Earnings Results Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles MercadoLibre Down 23% After Missed Earnings: Time to Buy the Dip?Roblox Stock Soars 22% After Q3 Earnings – A Turning Point Ahead?Apple Earnings - When Really Good Just Isn’t Good Enough Roblox Stock Set for More Gains After Strong Earnings ReportAmazon: Why Analysts Think It's a Solid Buy Ahead of EarningsLam Research Proves Analysts Wrong with a Strong Earnings ReportPulteGroup Earnings Signal Potential Entry Points for Investors Trump’s Back, but DC’s Coming for Your Money! (Ad)Trump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy with a heavy hand—building up infrastructure, slapping tariffs on imports, and going all-in on U.S. jobs. But here's the kicker: while Trump's focused on making America stronger, the Washington elite is ready to fight back…Get ahead of the game with 3 proven strategies to protect your retirement from Washington's next mov This page (NASDAQ:ABCL) was last updated on 11/17/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredThere is a little known company that is changing warfareWith geo - political instability around the world investors are flocking to defense contract stocks. There...Reticulate | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AbCellera Biologics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share AbCellera Biologics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
